GOED launches digital resource detailing EU omega-3 health claims

GOED-launches-digital-resource-detailing-EU-omega-3-health-claims.jpg

The Global Organization for EPA and DHA Omega-3s (GOED) has made available a resource that better explains the omega-3 health claims approved in the European Union.

Available at AlwaysOmega3s.com, the infographic is the latest initiative by the organisation to educate consumers about omega-3s and the health benefits the fatty acids are strongly linked to.

“The European Food Safety Authority (EFSA) recognises the importance of Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) to support a variety of health benefits,” the infographic states.

“Getting a health claim approved in the European Union (EU) is a rigorous process, but the science behind EPA and DHA omega-3s is so convincing that in the EU there are not one, but nine approved health claims.

The health claims

These claims include DHA contribution to the normal development of the eye of the foetus and breastfed infants, when taken during pregnancy.

The maternal intake of DHA also contributes to the normal brain development of the foetus and breastfed infants.

Other claims include DHA’s role in contributing to the maintenance of normal brain function and the maintenance of normal vision as well as visual development in infants up to 12 months of age.

According to EFSA, DHA, when combined with EPA, contribute to the normal function of the heart.

DHA and EPA (and DHA alone) also contribute to the maintenance of normal blood triglyceride levels and the maintenance of normal blood pressure.